FDA Inspection
Glenmark Pharmaceuticals LimitedGlenmark Pharmaceuticals Limited – FDA Inspection, Feb 21, 2020
Record Details
This FDA Inspection record concerns Glenmark Pharmaceuticals Limited, with an inspection on February 21, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 21, 2020
- Product Type
- Drugs
View Company Profile
ID · 7480abca-376a-48b0-8d6c-47a32ec70561
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1122444
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Glenmark Pharmaceuticals Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| November 28, 2025 | Not classified | Office of Inspections and Investigations | |
| September 20, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 15, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 17, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 21, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Glenmark Pharmaceuticals Limited
- FDA Inspection 1298220 - 2025-11-28
- FDA Inspection 1252922 - 2024-09-20
- FDA Inspection 1226884 - 2023-12-15
- FDA Inspection 1065438 - 2018-08-17
- FDA Inspection 1025068 - 2017-07-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.